Home / Central Data Catalog / FRESH-PEF2943-EN
central

Patient reported Instanyl® Use Study

France, 2011 - 2012
Reference ID
FRESH-PEF2943-en
Producer(s)
Patrick;BLIN, Nicholas;MOORE
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
37
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Access policy
  • Data Access
  • Contacts

    • Identification

    Survey ID number

    FRESH-PEF2943-en
    Title

    Patient reported Instanyl® Use Study
    Abbreviation or Acronym

    PIUS
    Country
    Name Country code
    France fr
    Kind of Data

    ['Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Oncology health theme
    Behavioral determinants: Addiction health determinant
    Healthcare system determinants: Use of care health determinant
    Behavioral determinants health determinant
    Healthcare system determinants health determinant
    Keywords
    opioid breakthrough pain misuse abuse risk management plan Instanyl® fentanyl cancer Pharmacoepidemiology Department of Pharmacology Bordeaux

    Coverage

    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Patient who received a dispensation of Instanyl® from non-hospital pharmacies","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    Patrick;BLIN
    Nicholas;MOORE
    Producers
    Name Role
    UNIVERSITE DE BORDEAUX sponsor
    Funding Agency/Sponsor
    Name
    TAKEDA FRANCE SAS

    Study authorization

    Agency
    Agency name
    CNIL
    CESREES

    Sampling

    Sample frame

    Unit Type

    ['Through independent healthcare practitioners']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2011-01-01 2012-01-01
    Time Method

    One-time cross-sectional study
    Mode of data collection
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity Health care consumption and services

    Access policy

    Notes

    Ownership of study data is the subject of an agreement between the University of Bordeaux Segalen and the pharmaceutical company

    Data Access

    Availability Status

    {"value":"To be defined","extLink":[]}

    Contacts

    Contacts
    Name Email
    Patrick;BLIN patrick.blin@u-bordeaux.fr
    Nicholas;MOORE nicholas.moore@u-bordeaux.fr
    Back to Catalog